Cargando…

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

INTRODUCTION: Cardiovascular events are common in COVID-19. While the use of anticoagulation during hospitalization has been established in current guidelines, recommendations regarding antithrombotic therapy in the post-discharge period are conflicting. METHODS: To investigate this issue, we conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Motloch, Lukas J., Jirak, Peter, Mirna, Moritz, Fiedler, Lukas, Davtyan, Paruir A., Lakman, Irina A., Gareeva, Diana F., Tyurin, Anton V., Gumerov, Ruslan M., Matskeplishvili, Simon T., Pavlov, Valentin N., Cai, Benzhi, Kopp, Kristen, Topf, Albert, Hoppe, Uta C., Pistulli, Rudin, Zagidullin, Naufal S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372296/
https://www.ncbi.nlm.nih.gov/pubmed/35966512
http://dx.doi.org/10.3389/fcvm.2022.916156